Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Halozyme Therapeutics Inc. (NASDAQ: HALO) closed at $53.00 up 1.67% from its previous closing price of $52.13. In other words, the price has increased by $1.67 from its previous closing price. On the day, 0.86 million shares were traded. HALO stock price reached its highest trading level at $53.13 during the session, while it also had its lowest trading level at $52.16.
Ratios:
For a deeper understanding of Halozyme Therapeutics Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.69 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.44. For the most recent quarter (mrq), Quick Ratio is recorded 6.21 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 5.19 whereas as Long-Term Debt/Eq ratio is at 5.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on October 07, 2024, Downgraded its rating to Equal Weight and sets its target price to $62 from $58 previously.
On September 19, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also upped its target price recommendation from $52 to $57.
Piper Sandler Downgraded its Overweight to Neutral on June 07, 2024, whereas the target price for the stock was revised from $48 to $51.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 08 ’24 when Torley Helen sold 10,000 shares for $54.00 per share. The transaction valued at 539,961 led to the insider holds 676,744 shares of the business.
Torley Helen sold 10,000 shares of HALO for $525,783 on Oct 09 ’24. The PRESIDENT AND CEO now owns 676,744 shares after completing the transaction at $52.58 per share. On Oct 09 ’24, another insider, HELEN TORLEY, who serves as the Officer of the company, bought 10,000 shares for $52.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HALO now has a Market Capitalization of 6713933824 and an Enterprise Value of 7718097920. As of this moment, Halozyme’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.55, and their Forward P/E ratio for the next fiscal year is 11.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.69 while its Price-to-Book (P/B) ratio in mrq is 23.17. Its current Enterprise Value per Revenue stands at 8.838 whereas that against EBITDA is 16.053.
Stock Price History:
Over the past 52 weeks, HALO has reached a high of $65.53, while it has fallen to a 52-week low of $32.83. The 50-Day Moving Average of the stock is -9.45%, while the 200-Day Moving Average is calculated to be 13.64%.
Shares Statistics:
For the past three months, HALO has traded an average of 1.37M shares per day and 1763230 over the past ten days. A total of 126.77M shares are outstanding, with a floating share count of 125.30M. Insiders hold about 1.09% of the company’s shares, while institutions hold 98.06% stake in the company. Shares short for HALO as of 1727654400 were 9854920 with a Short Ratio of 7.17, compared to 1724976000 on 10040022. Therefore, it implies a Short% of Shares Outstanding of 9854920 and a Short% of Float of 10.5399996.
